TABLE 2.
Intervention period | Control period | Mean difference | p‐value | |||
---|---|---|---|---|---|---|
BL | BL | Δ WK4 | Δ FU | Time × treatment | Treatment | |
TCH (mmol/L) | 5.77 ± 1.06 | 5.55 ± 1.21 | 0.01 ± 0.49 | −0.15 ± 0.92 | 0.648 | 0.547 |
TAG (mmol/L) | 1.35 ± 0.47 | 1.36 ± 0.52 | 0.19 ± 0.57 | 0.09 ± 0.57 | 0.411 | 0.497 |
HDL (mmol/L) | 1.33 ± 0.19 | 1.30 ± 0.16 | −0.07 ± 0.12* | 0.01 ± 0.13 | 0.035 | N/A |
LDL (mmol/L) | 3.82 ± 0.97 | 3.64 ± 1.07 | −0.02 ± 0.58 | −0.21 ± 0.73 | 0.430 | 0.366 |
CRP (mg/L) a | 3.35 ± 5.03 | 2.22 ± 2.30 | −1.40 ± 3.54 | −1.88 ± 4.71 | 0.332 | 0.099 |
Note. Values are means ± SD. Time × treatment and treatment effect (linear mixed model): *p < 0.05.
Abbreviations: BL, baseline; CRP, C‐reactive protein; FU, follow‐up; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; TAG, triacylglycerol; TCH, total cholesterol; WK4, week 4.
Statistics were performed after log‐transformation due to non‐normal distribution.